H Mo

Summary

Affiliation: Gilead Sciences
Country: USA

Publications

  1. doi request reprint Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors
    H Mo
    Department of Clinical Virology, Gilead Sciences Inc, Foster City, CA, USA
    J Viral Hepat 18:338-48. 2011
  2. doi request reprint Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naïve HCV patient isolates
    S C C Sun
    Department of Clinical Virology, Gilead Sciences, Inc, Foster City, CA 94404, USA
    J Viral Hepat 18:861-70. 2011

Collaborators

  • S C C Sun
  • A Bae
  • J Harris
  • K A Wong
  • X Qi
  • M D Miller

Detail Information

Publications2

  1. doi request reprint Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors
    H Mo
    Department of Clinical Virology, Gilead Sciences Inc, Foster City, CA, USA
    J Viral Hepat 18:338-48. 2011
    ..This method provides a framework for the evaluation of other classes of drugs that are bound by serum proteins but require the presence of serum for in vitro evaluation...
  2. doi request reprint Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naïve HCV patient isolates
    S C C Sun
    Department of Clinical Virology, Gilead Sciences, Inc, Foster City, CA 94404, USA
    J Viral Hepat 18:861-70. 2011
    ..In addition, the lack of correlation among the susceptibilities to three classes of HCV polymerase inhibitors evaluated here supports their possible combined use in a combination therapy strategy...